DRUGGIST DARK SPOT CORRWXTOR

Manufacturer
Shenzhen Xiaomai Manufacturing Co., Ltd.
Effective date
2024-03-05
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:10:08

Label at a glance#

ProductDRUGGIST DARK SPOT CORRWXTOR
Active ingredientASCORBIC ACID, ARBUTIN, NIACINAMIDE, DIGLYCOLIC ACID, 4-BUTYLRESORCINOL, KOJIC ACID, RETINOL
Label structure13 sections

Indications and uses

Lighten skin spots, even skin tone, and make skin brighter.

Dosage and administration

1. After cleansing the face, take an appropriate amount of spot lightening cream. 2. Apply evenly to the area on the face that needs to lighten spots, and massage gently until completely absorbed. 3. Use once in the morning and evening. Continuous use will provide better results.

Storage and handling

Please store in a cool, dry place away from direct sunlight.

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION


Arbutin7%
Niacinamide7%
4-Butylresorcinol7%
Kojic Acidl7%
Ascorbic Acid5%
Retinol5%
Glycolic Acid5%

Purpose

OTC - PURPOSE SECTION


Lighten skin spots

Uses

INDICATIONS & USAGE SECTION


Lighten skin spots, even skin tone, and make skin brighter.

Warnings

WARNINGS SECTION

For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children.If swallowed, get medical help or contacta Poison Control Center right away.

Do not use

DESCRIPTION SECTION

Do not use on damaged or broken skin

When using this product

OTC - WHEN USING SECTION

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

OTC - STOP USE SECTION

Stop use and ask a doctor if rash occurs

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If swallowed, get medical help or contacta Poison Control Center right away.

Ask Doctor

OTC - ASK DOCTOR SECTION

When Pregnant or breast-feeding.

Directions

DOSAGE & ADMINISTRATION SECTION

1. After cleansing the face, take an appropriate amount of spot lightening cream.
2. Apply evenly to the area on the face that needs to lighten spots, and massage gently until completely absorbed.
3. Use once in the morning and evening. Continuous use will provide better results.

Other information

STORAGE AND HANDLING SECTION

Please store in a cool, dry place away from direct sunlight.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aqua,Methylpropanediol,Butylene Glycol Stearate, Caprylic/Capric /Stearic Triglyceride,Tocopherol,Saccharomyces Polypeptides, BHT,Methylparaben, Propylparaben,Sodium Hyaluronate,Sodium Polyacrylate Starch,Trideceth-6,C18-21 Alkane.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83872-205DRUGGIST DARK SPOT CORRWXTOR (DARK SPOT CORRWXTOR) CREAM [SHENZHEN XIAOMAI MANUFACTURING CO., LTD.]1Unmatched20240307_12eac3e5-d452-6132-e063-6294a90a4a2e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83872-20583872-205-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
36591cb3-64c2-833a-e063-6394a90aea3612eac3e5-d452-6132-e063-6294a90a4a2e2025-05-30WarningsExact identifier
spl set id: 12eac3e5-d452-6132-e063-6294a90a4a2e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.